• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌手术中切缘阳性预测因素的系统评价及其对生存的影响。

Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival.

机构信息

Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada.

出版信息

Gastric Cancer. 2012 Sep;15 Suppl 1:S116-24. doi: 10.1007/s10120-011-0112-7. Epub 2011 Dec 3.

DOI:10.1007/s10120-011-0112-7
PMID:22138928
Abstract

BACKGROUND

Complete resection is the only definitive treatment available for gastric cancer. Factors associated with positive margins and their survival effects have been the subject of many studies, but the appropriate management for these patients is still debated. The objective of this review is to examine positive margins after gastric cancer resections by exploring predictive factors, impact on survival, and optimal strategies for re-resection.

METHODS

A systematic electronic literature search was conducted using Medline and EMBASE from January 1, 1998, to December 31, 2009. Studies on gastric or gastroesophageal junction adenocarcinoma that either investigated the predictors for positive margin or employed multivariate methods to analyze the survival effects of positive margins were selected.

RESULTS

Twenty-two studies incorporating 19355 patients were included in this review. Positive margins were associated with larger tumor size, deeper wall penetration, more extensive gastric involvement, greater nodal involvement, higher stage, diffuse histology, higher Borrmann type, lymphatic vessel involvement, and total gastrectomy. Patient survival was independently associated with margin status, and this survival effect was more prominent in early cancers in most studies that performed subgroup analyses.

CONCLUSIONS

The probability of acquiring positive margins is highly dependent on the biology and the extent of the tumor. There is a significant negative effect on survival, which is more prominent in cancers at early stages, making re-resection or a second operation important. Patients with more advanced disease can be offered more extensive surgery to remove disease, but this should be balanced against the risks of more extensive resections.

摘要

背景

完全切除是胃癌唯一的确定性治疗方法。与阳性切缘及其生存影响相关的因素已经成为许多研究的主题,但这些患者的适当治疗仍存在争议。本综述的目的是通过探讨阳性切缘的预测因素、对生存的影响以及再次切除的最佳策略,来研究胃癌切除术后的阳性切缘。

方法

使用 Medline 和 EMBASE 从 1998 年 1 月 1 日至 2009 年 12 月 31 日进行了系统的电子文献检索。选择了研究胃或胃食管交界处腺癌的阳性切缘预测因素或采用多变量方法分析阳性切缘对生存影响的研究。

结果

本综述共纳入了 22 项研究,共计 19355 例患者。阳性切缘与肿瘤较大、壁浸润较深、胃受累较广、淋巴结受累较多、分期较高、弥漫性组织学、较高的 Borrmann 类型、淋巴管受累和全胃切除术有关。患者的生存与切缘状态独立相关,并且在大多数进行亚组分析的研究中,这一生存效应在早期癌症中更为明显。

结论

获得阳性切缘的概率高度取决于肿瘤的生物学特性和肿瘤的侵袭范围。阳性切缘对生存有显著的负面影响,在早期癌症中更为明显,这使得再次切除或再次手术变得很重要。对于更晚期的疾病患者,可以提供更广泛的手术来清除疾病,但这需要权衡更广泛切除的风险。

相似文献

1
Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival.胃癌手术中切缘阳性预测因素的系统评价及其对生存的影响。
Gastric Cancer. 2012 Sep;15 Suppl 1:S116-24. doi: 10.1007/s10120-011-0112-7. Epub 2011 Dec 3.
2
Molecular-targeted first-line therapy for advanced gastric cancer.晚期胃癌的分子靶向一线治疗
Cochrane Database Syst Rev. 2016 Jul 19;7(7):CD011461. doi: 10.1002/14651858.CD011461.pub2.
3
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.辅助纳武利尤单抗联合化疗对比安慰剂联合化疗用于 D2 或更广泛淋巴结清扫术后的 III 期胃癌或胃食管结合部癌(ATTRACTION-5):一项随机、多中心、双盲、安慰剂对照的 III 期临床试验。
Lancet Gastroenterol Hepatol. 2024 Aug;9(8):705-717. doi: 10.1016/S2468-1253(24)00156-0. Epub 2024 Jun 18.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.术中冰冻切片分析用于诊断可疑盆腔肿块中的早期卵巢癌。
Cochrane Database Syst Rev. 2016 Mar 1;3(3):CD010360. doi: 10.1002/14651858.CD010360.pub2.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.

引用本文的文献

1
Real-World Experience of Clinical Outcomes of Microscopic Margin Positivity After Radical Gastrectomy from a Tertiary Cancer Center in Northeast India.印度东北部一家三级癌症中心根治性胃切除术后显微镜下切缘阳性临床结局的真实世界经验
Indian J Surg Oncol. 2025 Feb;16(1):290-295. doi: 10.1007/s13193-024-02081-y. Epub 2024 Sep 7.
2
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).《2024年韩国胃癌诊疗指南:基于证据的多学科方法(2022年指南更新)》
J Gastric Cancer. 2025 Jan;25(1):5-114. doi: 10.5230/jgc.2025.25.e11.
3
Adequate gross resection margin length ensuring pathologically complete resection in gastrectomy for gastric cancer: A systematic review and meta-analysis.

本文引用的文献

1
Prognosis and surgical treatment of gastric cancer invading adjacent organs.侵犯相邻器官的胃癌的预后及外科治疗
ANZ J Surg. 2010 Jul-Aug;80(7-8):510-4. doi: 10.1111/j.1445-2197.2010.05376.x.
2
Surgical outcomes and prognostic factors for T4 gastric cancers.T4 期胃癌的手术治疗效果及预后因素。
Asian J Surg. 2009 Oct;32(4):198-204. doi: 10.1016/S1015-9584(09)60395-X.
3
Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.印戒细胞组织学是胃腺癌不良预后的独立预测因子,与肿瘤的临床表现无关。
胃癌胃切除术中确保病理完全切除的足够切缘长度:一项系统评价和荟萃分析。
Ann Gastroenterol Surg. 2023 Dec 5;8(2):202-213. doi: 10.1002/ags3.12761. eCollection 2024 Mar.
4
The correlation between the margin of resection and prognosis in esophagogastric junction adenocarcinoma.食管胃结合部腺癌的切缘与预后的相关性。
World J Surg Oncol. 2023 Oct 9;21(1):316. doi: 10.1186/s12957-023-03202-7.
5
Textbook Outcome after Gastrectomy for Gastric Cancer Is Associated with Improved Overall and Disease-Free Survival.胃癌胃切除术后的教科书式结局与总体生存率和无病生存率的提高相关。
J Clin Med. 2023 Aug 21;12(16):5419. doi: 10.3390/jcm12165419.
6
A prospective Canadian gastroesophageal cancer database: What have we learned?前瞻性加拿大胃食管癌症数据库:我们学到了什么?
Can J Surg. 2023 Aug 8;66(4):E422-E431. doi: 10.1503/cjs.005122. Print 2023 Jul-Aug.
7
Surgical starting time of the day and survival in gastric cancer.一天中手术开始时间与胃癌患者的生存情况。
Sci Rep. 2023 Apr 28;13(1):6955. doi: 10.1038/s41598-023-33692-0.
8
Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach.《2022年韩国胃癌诊疗指南:基于证据的多学科方法》
J Gastric Cancer. 2023 Jan;23(1):3-106. doi: 10.5230/jgc.2023.23.e11.
9
Gastrectomy for Cancer: A 15-Year Analysis of Real-World Data from the University of Athens.胃癌切除术:来自雅典大学的 15 年真实世界数据分析。
Medicina (Kaunas). 2022 Dec 5;58(12):1792. doi: 10.3390/medicina58121792.
10
Significance of monocyte infiltration in patients with gastric cancer: A combined study based on single cell sequencing and TCGA.单核细胞浸润在胃癌患者中的意义:基于单细胞测序和TCGA的联合研究
Front Oncol. 2022 Nov 21;12:1001307. doi: 10.3389/fonc.2022.1001307. eCollection 2022.
Ann Surg. 2009 Dec;250(6):878-87. doi: 10.1097/SLA.0b013e3181b21c7b.
4
Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy.手术切缘阳性状态对接受胃切除术的胃癌患者的临床影响。
Ann Surg Oncol. 2009 Oct;16(10):2738-43. doi: 10.1245/s10434-009-0616-0. Epub 2009 Jul 28.
5
Prognostic significance of microscopic positive margins for gastric cancer patients with potentially curative resection.胃癌患者潜在可治愈性切除术后显微镜下阳性切缘的预后意义。
Ann Surg Oncol. 2009 Nov;16(11):3028-37. doi: 10.1245/s10434-009-0624-0. Epub 2009 Jul 22.
6
Appropriate selection of patients for combined organ resection in cases of gastric carcinoma invading adjacent organs.胃癌侵犯相邻器官时联合器官切除患者的合适选择。
J Surg Oncol. 2009 Aug 1;100(2):115-20. doi: 10.1002/jso.21306.
7
Resection line involvement after gastric cancer surgery: clinical outcome in nonsurgically retreated patients.胃癌手术后切缘受累情况:未接受再次手术治疗患者的临床结局
World J Surg. 2008 Dec;32(12):2661-7. doi: 10.1007/s00268-008-9747-x.
8
Surgical outcomes and survival after multiorgan resection for locally advanced gastric cancer.局部进展期胃癌多器官切除术后的手术结果与生存率
Am J Surg. 2009 Jul;198(1):25-30. doi: 10.1016/j.amjsurg.2008.06.031. Epub 2008 Sep 27.
9
Borrmann type IV: an independent prognostic factor for survival in gastric cancer.Borrmann Ⅳ型:胃癌生存的独立预后因素。
J Gastrointest Surg. 2008 Aug;12(8):1364-9. doi: 10.1007/s11605-008-0516-9. Epub 2008 May 31.
10
Two different surgical approaches in the treatment of adenocarcinoma at the gastroesophageal junction.治疗胃食管交界腺癌的两种不同手术方法。
World J Surg. 2008 Jun;32(6):1013-20. doi: 10.1007/s00268-008-9470-7.